HUTCHMED (China) (HCM) Long-Term Deferred Tax (2017 - 2025)
HUTCHMED (China)'s (HCM) quarterly Long-Term Deferred Tax came in at $12.4 million in Q4 2025, little changed year-on-year from $12.4 million in Q4 2024, and little changed on a QoQ basis from $12.4 million in Q4 2024.
HUTCHMED (China) (HCM) Long-Term Deferred Tax (2017 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 9 years of Long-Term Deferred Tax data on file, last reported at $12.4 million in Q4 2025.
- On a quarterly basis, Long-Term Deferred Tax changed 0.39% year-over-year to $12.4 million in Q4 2025; TTM through Dec 2025 was $12.4 million, a 0.39% change from a year earlier, with the FY2025 full-year figure at $12.4 million, changed 0.39% from the prior year.
- Long-Term Deferred Tax for Q4 2025 stood at $12.4 million, roughly flat from $12.4 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for HCM reached as high as $15.5 million in Q4 2023 and fell as low as $9.4 million in Q4 2021.
- Historically, Long-Term Deferred Tax has averaged $12.5 million across 5 years, with a median of $12.4 million in 2024.
- Across the five-year window, Long-Term Deferred Tax surged 520.53% in 2021 and decreased 19.46% in 2024, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $9.4 million in 2021, then soared by 34.62% to $12.7 million in 2022, then advanced by 22.12% to $15.5 million in 2023, then decreased by 19.46% to $12.4 million in 2024, then fell by 0.39% to $12.4 million in 2025.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $12.4 million in Q4 2025, $12.4 million in Q4 2024, and $15.5 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.40 Mn |
| Dec 31, 2024 | 12.45 Mn |
| Dec 31, 2023 | 15.46 Mn |
| Dec 31, 2022 | 12.66 Mn |
| Dec 31, 2021 | 9.40 Mn |
| Dec 31, 2020 | 1.52 Mn |
| Jun 30, 2020 | -2.39 Mn |
| Dec 31, 2019 | 815,000.00 |
| Jun 30, 2019 | 7.51 Mn |
| Mar 31, 2019 | 1.39 Mn |
| Dec 31, 2018 | 580,000.00 |
| Dec 31, 2017 | 32.30 Mn |